Karine Lacut

Brest, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Risk of venous thromboembolism in first-degree relatives of affected patients compared with general population.

Risk of venous thromboembolism in first-degree relatives of affected patients compared with general population.

Journal: Thrombosis research

Published: April 27, 2026

Inflammatory protein signatures associated with high rivaroxaban exposure.

Inflammatory protein signatures associated with high rivaroxaban exposure.

Journal: Biochemical pharmacology

Published: October 09, 2025

Epidemiology of venous thromboembolism during pregnancy and postpartum: results from the French prospective multicenter HEMOrrhage and venous THromboEmbolism in PostPartum study.

Epidemiology of venous thromboembolism during pregnancy and postpartum: results from the French prospective multicenter HEMOrrhage and venous THromboEmbolism in PostPartum study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 19, 2025

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.

Journal: Lancet (London, England)

Published: November 22, 2024

Full-dose rivaroxaban in patients with a history of bariatric surgery: bridging the knowledge gap through a phase 1 study.

Full-dose rivaroxaban in patients with a history of bariatric surgery: bridging the knowledge gap through a phase 1 study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 14, 2024

Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients.

Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients.

Journal: NEJM evidence

Published: February 06, 2024

Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.

Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.

Journal: Thrombosis research

Published: June 05, 2023

Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations.

Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations.

Journal: Pharmaceutics

Published: January 23, 2023

Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.

Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.

Journal: Seminars in thrombosis and hemostasis

Published: October 17, 2022

Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter.

Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter.

Journal: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

Published: September 15, 2022

Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study.

Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study.

Journal: Seminars in thrombosis and hemostasis

Published: June 30, 2022

Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.

Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.

Journal: Thrombosis and haemostasis

Published: June 18, 2022

Showing 1-12 of 96

Last Updated: 09/26/2026